Amylyx stock has surged on pipeline progress, but investors should understand the risks and long-term catalysts driving AMLX shares ...

All of them could be "forever" holdings, but the coming decade could prove surprisingly fruitful for each of these outfits.

Shares of Merck MRK rose nearly 6% on Friday after the company announced that the EMA’s Committee for Medicinal Products for ...

EU CHMP recommends approval of Merck’s Keytruda plus Padcev as perioperative treatment for adults with cisplatin-ineligible resectable muscle-invasive bladder cancer: Rahway, Ne ...

A speculative but compelling AI biotech investment can be built around Absci and its attempt to rewire drug discovery itself.